Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
127132501	12713250	1	I	20160819	20160826	20160902	20160902	EXP		US-ASTRAZENECA-2016SE93715	ASTRAZENECA		146.00	DY			Y	0.00000		20160903		OT	CL	CL

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
127132501	12713250	1	PS	SYNAGIS	PALIVIZUMAB	1	Intramuscular	50.0MG UNKNOWN			U	U	UNK		0	50	MG	INJECTION
127132501	12713250	2	SS	SYNAGIS	PALIVIZUMAB	1	Intramuscular	46.0MG UNKNOWN			U	U	UNK		0	46	MG	INJECTION

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
127132501	12713250	1	Product used for unknown indication
127132501	12713250	2	Product used for unknown indication

Outcome of event

Event ID	CASEID	OUTC COD
127132501	12713250	HO

Reactions reported

Event ID	CASEID	PT
127132501	12713250	Bronchitis
127132501	12713250	Pneumonia viral
127132501	12713250	Respiratory disorder
127132501	12713250	Respiratory syncytial virus infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
127132501	12713250	1	20160628	20160628	0
127132501	12713250	2	20160726	20160726	0